4-(2H-[1,2,4]Triazol-3-yl)-benzoic acid, 95.0%, 1g

p-Xylol, min. 99 %, zur Synthese, 2.5 l, Glasverpackung

5-Chloro-2-fluoronicotinic acid, 98.0%, 25g

4-methylmorpholine-2,6-dione, 95.0%, 5g

1,3-Dimethyl-1H-indazol-4-yl-4-boronic acid, 95.0%, 5g

2-Iodobenzaldehyde>98.0%(GC)5g

2-Nitro-4-(trifluoromethyl)phenylacetic acid, 97.0%, 25g

4-(2-Carboxy-1-(2,4-diaminopteridin-6-yl)pent-4-yn-2-yl)benzoic acid, 98%, 250mg

1H-Pyrazolo[3,4-c]pyridin-5-amine, 95.0%, 1g

(S)-di-tert-butyl 2-carbamoylpiperazine-1,4-dicarboxylate, 97%, 250mg

2-(4-tert-Butylbenzoyl)-5-methylpyridine, 97.0%, 1g

7-(2-Bromoethyl)-2-(furan-2-yl)-7H-pyrazolo[4,3-e][1,2,4]triazolo[1,5-c]pyrimidin-5-amine, 97%, 1g

17,21-Dihydroxy-pregn-4-ene-3,20-dione, 95.0%, 1g